Braskem (BRKM5) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Recurring EBITDA reached $320 million (US$320 million/R$1.7 billion) in Q2 2024, up 39–46% sequentially and 128–137% year-over-year, driven by improved international petrochemical spreads and strong sales in Mexico and Brazil.
Net loss was R$3.7 billion in Q2 2024 and R$5.3 billion for H1 2024, mainly due to negative exchange rate impacts and higher financial expenses.
Liquidity remained robust at US$2.8 billion, with an additional US$1 billion credit line, covering debt maturities for 61 months.
Strategic progress included decarbonization initiatives, expansion of partnerships, and 75–77% completion of the Mexico ethane import terminal.
Significant remediation and social measures advanced in Alagoas, with over R$10.6 billion disbursed and R$15.9 billion provisioned.
Financial highlights
Recurring EBITDA rose 39–46% sequentially and 128% year-over-year to US$320 million/R$1.7 billion.
Operational cash generation was R$1.1 billion (US$214–240 million), up 9–15% sequentially.
Net debt stood at US$5.6 billion, with leverage at 6.79x, improved from 8.13x in Q1 2024.
Gross margin improved to 7.0% from 3.9% year-over-year.
Cash and cash equivalents at period end were R$14,213 million.
Outlook and guidance
Q3 2024 expected to see improved utilization rates in Brazil and green polyethylene as production resumes post-weather event.
Anticipated sales volume increase in Q3 due to greater product availability and improved demand, especially in consumer goods and sanitation.
Ethane import terminal in Mexico expected to be operational in Q1 2025, supporting full production capacity.
Management expects continued volatility due to currency fluctuations and global macroeconomic uncertainty.
Decarbonization initiatives in Alagoas and Rio Grande do Sul to reduce CO2 emissions by up to 200kt/year by 2026.
Latest events from Braskem
- EBITDA surged 121% to US$224M, but Alagoas-related risks remain significant.BRKM5
Q1 20259 Jul 2026 - EBITDA surged 104% sequentially, but net loss and high leverage persisted amid legal and market headwinds.BRKM5
Q3 20259 Jul 2026 - Recurring EBITDA fell 49% and net loss reached R$10,961m amid high leverage and industry downturn.BRKM5
Q4 20258 Jul 2026 - EBITDA rose 76% sequentially, but leverage, cash burn, and legal risks remain high.BRKM5
Q1 20267 Jul 2026 - EBITDA plunged 67%, leverage hit 10.59x, and legal, market, and cash flow risks remain.BRKM5
Q2 20257 Jul 2026 - EBITDA up 46% to US$1.1B, but FX losses led to a net loss; strong liquidity and green focus.BRKM5
Q4 20243 Jul 2026 - EBITDA hit a two-year high on margin gains, but legal and currency risks remain.BRKM5
Q3 20243 Jul 2026 - 2030 targets: 1M tons each of bio-based and recycled products, with ambitious decarbonization goals.BRKM5
Investor Day 202412 Jan 2026